{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T14:45:18Z","timestamp":1767969918082,"version":"3.49.0"},"reference-count":21,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,10,28]],"date-time":"2022-10-28T00:00:00Z","timestamp":1666915200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p><jats:bold>Background:<\/jats:bold> In the Montreal classification, L4 Crohn\u2019s disease (CD) is defined as an ileal disease, including L4-esophagogastric duodenum (EGD), L4-jejunum, and L4-proximal ileal involvement. According to the previous studies, the prognosis of L4 disease was worse than that of non-L4 disease. Among L4 diseases, the phenotypes of L4-jejunum and L4-proximal ileum indicated that the risk of abdominal surgery was higher. However, the prognosis of L4-esophagogastroduodenal remains largely elusive. Therefore, we aim to investigate whether the prognosis differs between CD patients with and without esophagogastroduodenal involvement.<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold> In this study, patients with L4-EGD phenotype (<jats:italic>n<\/jats:italic> = 74) who underwent gastroscopy, ileocolonoscopy, biopsies, and CTE from 2018 to 2020 were compared with L4 non-EGD controls (<jats:italic>n<\/jats:italic> = 148) who were randomly selected at a ratio of 1:2 in the same period. Demographic information inclusive of disease conduct and location, important points of the surgery, and hospitalization have been collected. The distinction between L4-EGD patients and non-L4-EGD patients was identified by way of multivariable logistic regression analysis. The Kaplan\u2013Meier technique was used to consider the possibility of abdominal surgical operation and complications, observed by means of Cox percentage hazard fashions to decide if L4 EGD independently estimated the endpoints inclusive of the abdominal surgery and the occurrences of complications.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> L4-EGD group (<jats:italic>n<\/jats:italic> = 74) had a lower proportion of intestinal fistula than the control group (<jats:italic>n<\/jats:italic> = 148) (17.6% <jats:italic>versus<\/jats:italic> 34.5%; <jats:italic>p<\/jats:italic> = 0.009), and the probabilities of requiring abdominal surgery and multiple abdominal surgeries were also lower (21.6% <jats:italic>versus<\/jats:italic> 36.5%; <jats:italic>p<\/jats:italic> = 0.025), (6.8% <jats:italic>versus<\/jats:italic> 18.9%; <jats:italic>p<\/jats:italic> = 0.016), respectively. The frequency of hospitalization was lower in the L4-EGD group than in the control group (3-7 <jats:italic>versus<\/jats:italic> 4\u20139; <jats:italic>p<\/jats:italic> = 0.013). L4-EGD phenotype was found to be an independent protective factor for abdominal surgery and intestinal fistula in the Cox regression model, with HRs of 0.536 (95%CI: 0.305\u20130.940; <jats:italic>p<\/jats:italic> = 0.030) and 0.478 (95%CI: 0.259\u20130.881; <jats:italic>p<\/jats:italic> = 0.018), respectively.<\/jats:p><jats:p><jats:bold>Conclusion:<\/jats:bold> Our data suggest that the L4-EGD phenotype may have a better prognosis compared to the Non-L4-EGD phenotype. Our data may advocate a revision of the Montreal classification including separate designations for L4-EGD disease.<\/jats:p>","DOI":"10.3389\/fphar.2022.963892","type":"journal-article","created":{"date-parts":[[2022,10,28]],"date-time":"2022-10-28T04:32:50Z","timestamp":1666931570000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":6,"title":["Crohn\u2019s disease patients with L4-esophagogastroduodenal phenotype is associated with a better prognosis: A retrospective cohort study"],"prefix":"10.3389","volume":"13","author":[{"given":"Jingrong","family":"Weng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xutao","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-fan","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-cheng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jia-wei","family":"Cai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peng-cheng","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuming","family":"Rong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yifeng","family":"Zou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lixin","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,10,28]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1038\/s41575-021-00424-6","article-title":"Location is important: Differentiation between ileal and colonic Crohn's disease","volume":"18","author":"Atreya","year":"2021","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1002\/ibd.20804","article-title":"Upper gastrointestinal tract phenotype of Crohn's disease is associated with early surgery and further hospitalization","volume":"15","author":"Chow","year":"2009","journal-title":"Inflamm. Bowel Dis."},{"key":"B3","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1055\/s-2007-1010544","article-title":"Crohn\u2019s disease of the upper gastrointestinal tract","volume":"24","author":"Dancygier","year":"1992","journal-title":"Endoscopy"},{"key":"B4","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1097\/00054725-200105000-00006","article-title":"Crohn's disease of the esophagus: Clinical features and outcomes","volume":"7","author":"Decker","year":"2001","journal-title":"Inflamm. Bowel Dis."},{"key":"B5","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.bpg.2012.01.019","article-title":"Small bowel endoscopy in inflammatory bowel disease","volume":"26","author":"Despott","year":"2012","journal-title":"Best. Pract. Res. Clin. Gastroenterol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/0016-5085(91)90202-v","article-title":"The epidemiology of inflammatory bowel disease: A large, population-based study in Sweden","volume":"100","author":"Ekbom","year":"1991","journal-title":"Gastroenterology"},{"key":"B7","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1097\/00054725-200002000-00002","article-title":"A simple classification of Crohn's disease: Report of the working party for the world congresses of gastroenterology, Vienna 1998","volume":"6","author":"Gasche","year":"2000","journal-title":"Inflamm. Bowel Dis."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1093\/ecco-jcc\/jjy121","article-title":"Upper gastrointestinal tract involvement in Crohn's disease: Frequency, risk factors, and disease course","volume":"12","author":"Greuter","year":"2018","journal-title":"J. Crohns Colitis"},{"key":"B9","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1097\/00054725-199911000-00006","article-title":"Treatment of severe esophageal Crohn's disease with infliximab","volume":"5","author":"Heller","year":"1999","journal-title":"Inflamm. Bowel Dis."},{"key":"B10","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/ajg.2012.389","article-title":"Relationship between proximal Crohn's disease location and disease behavior and surgery: A cross-sectional study of the IBD genetics consortium","volume":"108","author":"Lazarev","year":"2013","journal-title":"Am. J. Gastroenterol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/ajg.2012.389","article-title":"Relationship between proximal Crohn's disease location and disease behavior and surgery: A cross-sectional study of the IBD genetics consortium","volume":"108","author":"Lazarev","year":"2013","journal-title":"Am. J. Gastroenterol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1002\/ibd.21493","article-title":"Pediatric modification of the montreal classification for inflammatory bowel disease: The paris classification","volume":"17","author":"Levine","year":"2011","journal-title":"Inflamm. Bowel Dis."},{"key":"B13","doi-asserted-by":"publisher","first-page":"4811101","DOI":"10.1038\/ajg.2018.27","article-title":"ACG clinical guideline: Management of Crohn's disease in adults","volume":"113113","author":"Lichtenstein","year":"20182018","journal-title":"Am. J. Gastroenterol.Am J. Gastroenterol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1756284818777938","DOI":"10.1177\/1756284818777938","article-title":"Different clinical outcomes in Crohn's disease patients with esophagogastroduodenal, jejunal, and proximal ileal disease involvement: Is L4 truly a single phenotype?","volume":"11","author":"Mao","year":"2018","journal-title":"Ther. Adv. Gastroenterol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1111\/j.1572-0241.2007.01652.x","article-title":"New serological markers for inflammatory bowel disease are associated with earlier age at onset, complicated disease behavior, risk for surgery, and NOD2\/CARD15 genotype in a Hungarian IBD cohort","volume":"103","author":"Papp","year":"2008","journal-title":"Am. J. Gastroenterol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1097\/MCG.0b013e3182705f9e","article-title":"Long-term prognosis of the jejunal involvement of Crohn's disease","volume":"47","author":"Park","year":"2013","journal-title":"J. Clin. Gastroenterol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"610767","DOI":"10.1155\/2014\/610767","article-title":"Endoscopic and pathologic changes of the upper gastrointestinal tract in Crohn's disease","volume":"2014","author":"Sakuraba","year":"2014","journal-title":"Biomed. Res. Int."},{"key":"B18","doi-asserted-by":"publisher","first-page":"5A","DOI":"10.1155\/2005\/269076","article-title":"Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: Report of a working party of the 2005 montreal world congress of gastroenterology","volume":"19","author":"Silverberg","year":"2005","journal-title":"Can. J. Gastroenterol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1690","DOI":"10.1111\/j.1440-1746.2007.05145.x","article-title":"Education and imaging. Gastrointestinal: Gastric Crohn\u2019s disease","volume":"22","author":"Tseng","year":"2007","journal-title":"J. Gastroenterol. Hepatol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1097\/00054725-200111000-00010","article-title":"Proximal Crohn\u2019s disease: Review of the clinicopathologic features and therapy","volume":"7","author":"Van Hogezand","year":"2001","journal-title":"Inflamm. Bowel Dis."},{"key":"B21","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/s0016-5107(97)70100-7","article-title":"A bamboo joint-like appearance of the gastric body and cardia: Possible association with Crohn's disease","volume":"46","author":"Yokota","year":"1997","journal-title":"Gastrointest. Endosc."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2022.963892\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,28]],"date-time":"2022-10-28T04:32:52Z","timestamp":1666931572000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2022.963892\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,28]]},"references-count":21,"alternative-id":["10.3389\/fphar.2022.963892"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2022.963892","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,28]]},"article-number":"963892"}}